Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Bryan Haugen to Reverse Transcriptase Polymerase Chain Reaction

This is a "connection" page, showing publications Bryan Haugen has written about Reverse Transcriptase Polymerase Chain Reaction.

 
Connection Strength
 
 
 
0.480
 
  1. Morrison JA, Pike LA, Sams SB, Sharma V, Zhou Q, Severson JJ, Tan AC, Wood WM, Haugen BR. Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer. Mol Cancer. 2014 Mar 19; 13:62.
    View in: PubMed
    Score: 0.101
  2. Bauerle KT, Schweppe RE, Haugen BR. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion. Mol Cancer. 2010 May 21; 9:117.
    View in: PubMed
    Score: 0.078
  3. Sharma V, Hays WR, Wood WM, Pugazhenthi U, St Germain DL, Bianco AC, Krezel W, Chambon P, Haugen BR. Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis. Endocrinology. 2006 Mar; 147(3):1438-51.
    View in: PubMed
    Score: 0.057
  4. Klopper JP, Hays WR, Sharma V, Baumbusch MA, Hershman JM, Haugen BR. Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment. Mol Cancer Ther. 2004 Aug; 3(8):1011-20.
    View in: PubMed
    Score: 0.052
  5. Haugen BR, Larson LL, Pugazhenthi U, Hays WR, Klopper JP, Kramer CA, Sharma V. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids. J Clin Endocrinol Metab. 2004 Jan; 89(1):272-80.
    View in: PubMed
    Score: 0.050
  6. McDermott NB, Gordon DF, Kramer CA, Liu Q, Linney E, Wood WM, Haugen BR. Isolation and functional analysis of the mouse RXRgamma1 gene promoter in anterior pituitary cells. J Biol Chem. 2002 Sep 27; 277(39):36839-44.
    View in: PubMed
    Score: 0.045
  7. Sugawara M, Matsuzuka F, Fukata S, Kuma K, Moatamed F, Haugen BR. Excessive survivin expression in thyroid lymphomas. Hum Pathol. 2002 May; 33(5):524-7.
    View in: PubMed
    Score: 0.044
  8. Lehner R, Enomoto T, McGregor JA, Shroyer L, Haugen BR, Pugazhenthi U, Shroyer KR. Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma. Acta Obstet Gynecol Scand. 2002 Feb; 81(2):162-7.
    View in: PubMed
    Score: 0.044
  9. McDermott MT, Haugen BR, Gordon DF, Wood WM, Brown NS, Bauer CA, Garrity MJ, Kleinschmidt-DeMasters BK, Lillehei KO, Samuels MH, Bright TM, Ridgway EC. Reverse transcription polymerase chain reaction analysis of pituitary hormone, Pit-1 and steroidogenic factor-1 messenger RNA expression in pituitary tumors. Pituitary. 1999 Nov; 2(3):217-24.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)